Rubicon Organics Inc. Announces Overnight Marketed Public Offering of Units
2019年8月8日 - 4:34AM
Rubicon Organics Inc. (CSE: ROMJ) (OTCQX: ROMJF)
(“Rubicon” or the “Corporation”) is pleased to announce that it has
filed a preliminary short form prospectus (the “Preliminary
Prospectus”) in connection with an overnight marketed public
offering (the "Offering") of units ("Units"), for anticipated
aggregate gross proceeds of up to approximately $7 million, with
each Unit comprised of one common share (each a "Common Share") and
one Common Share purchase warrant (a "Warrant"). It is anticipated
that the price of the Units will be $2.70 and the exercise price of
the Warrant Share will be $3.50.
Each Warrant will entitle the holder thereof to
acquire one additional Common Share (each a "Warrant Share") and is
expected to have a 30-month term, subject to accelerated expiry if
the volume-weighted average price of the Common Shares is equal to
or greater than $3.80 for 20 consecutive trading days.
The Preliminary Prospectus was filed in each of
the provinces of Canada (other than Quebec) and the Offering is
being conducted by a syndicate of Agents, led by Desjardins Capital
Markets (the “Agents”).
The Corporation will also grant the Agents an
Over-Allotment Option to purchase up to a number of additional
Units equal to 15% of the Units sold pursuant to the Offering,
exercisable in whole or in part at any time up to 30 days after and
including the closing date of the Offering, which may be exercised
for Common Shares, Warrants or a combination thereof (the
“Over-Allotment Option”).
The Corporation intends to use the proceeds from
the Offering for the continued optimization of its Delta BC
facility and general corporate and working capital purposes.
The Offering is expected to close on or about
August 23, 2019 and is subject to certain conditions including, but
not limited to, the receipt of all necessary approvals, including
the approval of the Canadian Stock Exchange, and the entering into
of an agency agreement between the Corporation and the Agents.
THIS NEWS RELEASE DOES NOT CONSTITUTE AN OFFER
TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY OF THE SECURITIES
IN THE UNITED STATES. THE SECURITIES HAVE NOT BEEN AND WILL NOT BE
REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS
AMENDED (THE “U.S. SECURITIES ACT”) OR ANY STATE SECURITIES LAWS
AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR TO U.S.
PERSONS UNLESS REGISTERED UNDER THE U.S. SECURITIES ACT AND
APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM SUCH
REGISTRATION IS AVAILABLE.
ABOUT RUBICON ORGANICS INC.
Rubicon Organics Inc. is a Licensed Producer
focused on building certified organic, super-premium cannabis
brands at its flagship 125,000 sq. ft. state-of-the-art hybrid
greenhouse located on a 20-acre property in Delta, BC, Canada.
Management has unparalleled cannabis and organic farming expertise
as well as prior successful commercialization of cannabis with
Whistler Medical Marijuana Company, which was purchased by Aurora
Cannabis in January 2019 for $175 million.
The Corporation is currently ramping up to
produce approximately 11,000 kg of certified organic, super-premium
and environmentally sustainable cannabis in 2020 and on creating
super-premium brands in Canada. In the United States, the
Corporation owns a 40,000 square-foot, high-tech hybrid greenhouse
in Washington state which is leased to a state-licensed operator
applying Rubicon Organics’ proprietary organic cultivation methods.
The Corporation also owns two award-winning U.S. cannabis brands:
1964 Supply Co.TM in California and Doctor & Crook Co.TM in
Washington; and has exclusive licensing rights in Washington for
iconic lifestyle and cannabis brand, Cookies.
CONTACT INFORMATION
Corporate:Shirley AnthonyDirector, Investor
RelationsPhone: +1 (437) 929-1964Email: ir@rubiconorganics.com
The CSE does not accept responsibility
for the adequacy or accuracy of this press release.
Cautionary Statement Regarding Forward
Looking Information
This press release contains forward-looking
information within the meaning of applicable securities laws. All
statements that are not historical facts, including without
limitation, statements regarding future estimates, plans, programs,
forecasts, projections, objectives, assumptions, expectations or
beliefs of future performance, statements regarding the anticipated
terms of the Offering, the anticipated use of proceeds from the
Offering, the proposed timing of the Offering, and Rubicon
Organics' proposed brand launches and path to market are
"forward-looking statements". Forward-looking information can be
identified by the use of words such as “will” or variations of such
word or statements that certain actions, events or results "will"
be taken, occur or be achieved. Such forward-looking statements
involve known and unknown risks, uncertainties and other factors
that may cause actual results, events or developments to be
materially different from any future results, events or
developments expressed or implied by such forward looking
statements. The forward-looking information in this press release
is based upon certain assumptions that management considers
reasonable in the circumstances, including that its capital needs
will be as currently projected. Risks and uncertainties associated
with the forward looking information in this press release include,
among others, dependence on obtaining and maintaining regulatory
approvals, including market conditions, receipt of required
regulatory approvals, unexpected or unplanned expenditures
requiring a diversion of planned use of proceeds, acquiring and
renewing state, local or other licenses and any inability to obtain
all necessary governmental approvals licenses and permits to
complete construction of its proposed facilities in a timely
manner; engaging in activities which currently are illegal under
U.S. federal law and the uncertainty of existing protection from
U.S. federal or other prosecution; regulatory or political change
such as changes in applicable laws and regulations, including U.S.
state-law legalization, particularly in California, due to
inconsistent public opinion, perception of the medical-use and
adult-use marijuana industry, bureaucratic delays or inefficiencies
or any other reasons; any other factors or developments which may
hinder market growth; Rubicon Organics' limited operating history
and lack of historical profits; reliance on management; and the
effect of capital market conditions and other factors on capital
availability; competition, including from more established or
better financed competitors; and the need to secure and maintain
corporate alliances and partnerships, including with customers and
suppliers. These factors should be considered carefully and readers
are cautioned not to place undue reliance on such forward-looking
statements. Although Rubicon Organics has attempted to identify
important risk factors that could cause actual actions, events or
results to differ materially from those described in
forward-looking statements, there may be other risk factors that
cause actions, events or results to differ from those anticipated,
estimated or intended. There can be no assurance that
forward-looking statements will prove to be accurate, as actual
results and future events could differ materially from those
anticipated in forward-looking statements. Rubicon Organics assumes
no obligation to update any forward-looking statement, even if new
information becomes available as a result of future events, new
information or for any other reason except as required by law.
Rubicon Organics (CSE:ROMJ)
過去 株価チャート
から 12 2024 まで 1 2025
Rubicon Organics (CSE:ROMJ)
過去 株価チャート
から 1 2024 まで 1 2025